[1]
M. W. Saif, K. Kaley, M. Brennan, M. C. Garcon, G. Rodriguez, and T. Rodriguez, “A Retrospective Study of Capecitabine/Temozolomide (CAPTEM) Regimen in the Treatment of Metastatic Pancreatic Neuroendocrine Tumors (pNETs) after Failing Previous Therapy”, JOP. J Pancreas (Online), vol. 14, no. 5, pp. 498–501, Sep. 2013.